Preferred Label : recombinant FVIIa;

MeSH note : developed for treatment of bleeding episodes in persons with hemophilia complicated by inhibitor antibodies;

CISMeF synonym : eptacog alfa; novo seven;

MeSH synonym : rFVIIa; recombinant factor VIIa; recombinant coagulation factor viia; coagulation factor viia recombinant human;

MeSH hyponym : novoseven;

MeSH Related Number : 102786-61-8;

CISMeF hyponym : eptacog alfa activé;

Is substance : O;

UNII : AC71R787OV;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/cevenfacta
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
eptacog beta
eptacog beta
recombinant FVIIa
recombinant FVIIa
coagulation factor VIIa
product surveillance, postmarketing
adult
adolescent
blood loss, surgical
blood loss, surgical
injections, intravenous
hemophilia A
Genetic Engineering

---
https://www.has-sante.fr/jcms/p_3456306/fr/novoseven-eptacog-alfa-active-hemorragies-du-post-partum-severes
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
coagulation factor VIIa
recombinant FVIIa
injections, intravenous
evaluation of the transparency committee
eptacog alfa
postpartum hemorrhage

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69705653
2014
false
false
false
France
French
summary of product characteristics
package leaflet
solution, nos
injection, nos
powders
solutions
solvent, nos
activator appliances
injections
eptacog alfa
solutions
recombinant FVIIa
recombinant proteins
factor VIIa

---
https://www.ema.europa.eu/medicines/human/EPAR/NovoSeven
2012
false
United Kingdom
French
English
syndication feed
Contraindications, Procedure
hemorrhage
surgical procedures, operative
hemorrhage
factor VIIa
factor VIIa
factor VIIa
factor VIIa
treatment outcome
drug evaluation
recombinant proteins
recombinant proteins
recombinant proteins
recombinant proteins
hemostasis, surgical
blood coagulation disorders
injections, intravenous
recombinant FVIIa
coagulation factor VIIa
factor VIIa
recombinant proteins
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug

---
http://www.cochrane.org/fr/CD005011
2012
false
France
United Kingdom
French
french abstract
meta-analysis
recombinant FVIIa
factor VIIa
recombinant proteins
hemorrhage
hemorrhage
treatment outcome

---
https://www.cadth.ca/fr/facteur-vii-active-recombinant-dans-la-prevention-de-lhemorragie-non-liee-lhemophilie-etude
https://www.cadth.ca/sites/default/files/pdf/457B_Executive_Summary_f.pdf
2010
true
Canada
French
recombinant FVIIa
factor VIIa
recombinant proteins
hemorrhage
factor VIIa
recombinant proteins
health technology assessment
french abstract
economic evaluation
treatment outcome

---
https://www.revmed.ch/RMS/2008/RMS-176/Hemorragie-de-la-delivrance-prevention-embolisation-arterielle-et-facteur-VIIa-recombinant
2008
false
true
false
Switzerland
journal article
arteries
postpartum hemorrhage
recombinant FVIIa
factor VIIa

---
http://www.has-sante.fr/portail/display.jsp?id=c_245508
2004
France
French
factor VIIa
recombinant proteins
hemorrhage
hemorrhagic disorders
recombinant FVIIa
coagulation factor VIIa
factor VIIa
recombinant proteins
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_400146
2004
France
French
factor VIIa
recombinant proteins
recombinant FVIIa
coagulation factor VIIa
evaluation of the transparency committee

---
Nous contacter.
13/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.